Genfit press release
WebJan 24, 2024 · GENFIT annonce son calendrier financier pour 2024. Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 24 janvier 2024 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies du foie dont les besoins …
Genfit press release
Did you know?
WebJul 27, 2024 · GENFIT Officially Terminates RESOLVE-IT Trial of Elafibranor in NASH July 22, 2024 Impact: High GENFIT has officially terminated its pivotal RESOLVE-IT trial of elafibranor for the treatment of NASH with fibrosis after it … WebGenfit press release ( NASDAQ: GNFT ): FY GAAP EPS of -€0.48. Revenue of €26.57M (-69.0% Y/Y). Now read: Numinus Wellness GAAP EPS of -C$0.03, revenue of C$5.35M …
WebJul 22, 2024 · Lille, Cambridge, July 22, 2024– GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced the discontinuation... WebSep 19, 2024 · In 2024, GENFIT signed an exclusive licensing agreement with IPSEN to develop, manufacture and commercialize elafibranor in PBC and other indications. 2 …
WebJean-François Mouney, chairman & CEO of GENFIT, commented: “We are very enthusiastic to announce this agreement, which represents a major step in GENFIT’s commercial … WebFeb 28, 2024 · This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995, in relation to ...
WebDec 17, 2024 · Paris (France); December 17, 2024, Ipsen (Euronext: IPN; ADR: IPSEY) and GENFIT (Nasdaq and Euronext: GNFT), have entered into a long-term strategic …
WebSep 28, 2024 · LILLE, FRANCE; CAMBRIDGE, MA; & BURLINGTON, N.C.—Sep. 28, 2024— GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, and LabCorp® (NYSE:LH), a leading global life sciences company that is focused on advancing health … batut beogradWebThis press release has been prepared in both French and English. In the event of any differences between the two texts, the French language version shall supersede. … batut do skakaniaWebMay 23, 2024 · Lille (France), Cambridge (Massachusetts, United States), May 23, 2024 – GENFIT (Euronext: GNFT – Nasdaq: GNFT) a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, today announced the launch of a … batut burgerWeb15 hours ago · The disbursement of employee participation in the profits of GENFIT SA in May 2024 for a total of €0.6 million for the financial year 2024, and The acquisition of … batute adalahWebLille (France), Cambridge (Massachusetts, United States), September 26, 2024– GENFIT (Nasdaq and Euronext: GNFT) a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, today announced Dr. Dean Hum’s appointment as President … tijuana homelessWebSep 19, 2024 · GENFIT will host a live conference call today, September 19, at 8:00am ET / 1:00pm GMT / 2:00pm CET in English and in French. Sep 19, 2024 (GLOBE … tijuana hoodieWebNov 9, 2024 · Lille, France; Cambridge, MA; November 09, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the … batutegin